Showing results (231-240 of 715) with videos related to

Sort By:
Pageof 72
Journal of Migration and Health|October 2, 2025
Health outcomes of COVID-19 in immigrants versus native SpaniardsJose Manuel Ruiz Giardin, Nieves Mesa Plaza, Almudena Escribá Bárcena, et al.
Frontiers in Immunology|February 16, 2024
CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysisRaquel Ron, Javier Martínez-Sanz, Sabina Herrera, et al.
AIDS Research and Human Retroviruses|October 13, 2022
Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United StatesKarine Dubé, Chadwick K Campbell, Shadi Eskaf, et al.
AIDS Research and Therapy|July 25, 2006
IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cellsLaurel E Nomura, Brinda Emu, Rebecca Hoh, et al.
AIDS (London, England)|December 12, 2013
Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1Alonso Heredia, Charles Davis, Mohammed N Amin, et al.
AIDS (London, England)|September 10, 2020
Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agentsSushama Telwatte, Peggy Kim, Tsui-Hua Chen, et al.
AIDS (London, England)|July 12, 2012
Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patientsVan N Selby, Rebecca Scherzer, Christopher F Barnett, et al.
BMC Infectious Diseases|November 4, 2005
Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatmentSerena S Spudich, Annelie C Nilsson, Nicole D Lollo, et al.
JCI Insight|August 20, 2024
Mechanisms and efficacy of small molecule latency-promoting agents to inhibit HIV reactivation ex vivoJulie Janssens, Peggy Kim, Sun Jin Kim, et al.
Retrovirology|December 20, 2013
CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infectionJeffrey M Milush, Sandra López-Vergès, Vanessa A York, et al.
Pageof 72